Tron Logo
Trade on HitBTC
Like this video

Milestones Stem Cell

Stem Cells on Blockchain

At SCI, we are devoted to the international research, development, and implementation of stem cell therapy. We are also expanding our network with professionals, labs, clinics, hospitals, and nonprofit organizations. Our ultimate goal at SCI is to connect people who need treatment with the right dedicated solutions and professionals for their unique needs. At SCI, we believe such connections should be convenient and at your fingertips, just as so many other services are in modern society. We imagine a world where each and every person, no matter where they come from, will be able to connect with a Stem Cel Specialist instantly through our Stem Cell Innovations application (SCI Application), and in the same connection be able to decide when and how much confidential information to share with professionals.

2.3
1 0 expert ratings
Benchy 2.3
KYC
Experts
-
-
-
Review: coming soon PRO

Ended
Token
SCIA
Type
Price in ICO
0.1500 USD
Country
Whitelist/KYC
KYC
Restricted areas
USA, China, Cuba, Iran, Korea, Syria, Crimea
preICO start
17th Sep 2018
preICO end
29th Oct 2018
ICO start
21st Nov 2018
ICO end
17th Jan 2019
Visit ICO website
Report

Milestones

1
2013

Establishment of Camden RAD, LLC, a company devoted to stem cell research and development.

2
Q4 2017

Camden RAD, LLC is rebranded as Stem Cell Innovations, and a new company is established, based on blockchain technology.
Advanced research begins to determine market and development opportunities.

3
Q1 2018

Attended Token 2049 conference in Hong Kong.
Attended Stem Cell Summit at the University of California in Los Angeles (UCLA).
Attended CBC conference in San Francisco, CA.

4
Q2 2018

Attended ICO20 Summit in Santa Monica, CA.
Integration of smart contract technology is established.
Company headquarters incorporated in Gibraltar, GB.
Strategic efforts toward development begins.
Interviews with potential medical participants take place.

5
Q3 2018

Whitelist is scheduled to go live.
Token Sale starts.

6
Q4 2018

Token Sale ends and min max caps are assessed.
Distribution of Tokens to participants through ERC20 will commence.

7
Q1 2019

SCI will begin final testing and reporting based on blockchain technology being used.
Creation of a non-identical patient identification factor on Passive Blockchain Node will be initialized.
Demo testing for SCI Application v 1.0 will begin.

8
Q2 2019

Release of the SCI Application v1.1
Enrollment begins for doctors, patients, and stem cell laboratories in the United States

9
Q3 2019

Release of Market Surveillance strategy for further growth
Release SCI Application v2.0
Enrollment begins for professionals, patients, and stem cell laboratories in Middle East and across North Africa.
Announcement of first SCI Lab location and franchise expansion plan.

10
Q4 2019

Announcement of clinical development and research strategy in the stem cell field.
Public announcement regarding SCI achievements to date.
First ever online synthetic stem cell purchase through the SCI Application. Release SCI Application v3.0, fully functional platform for professionals and patients.

11
Q1 2020

Stem Cell Lab Evaluation report per first year of operation and development.
Release SCI earnings and financials report.
Release results of SCI's stem cell research and development to date.

12
Q2 2020

Expansion of SCI stem cell labs and clinics in China, Japan, South Korea, and India.
Begin charging membership fees (payable in Stem Cell Innovations tokens) for professional-facing portion of SCI application.

13
Q3 2020

Begin second phase of SCI stem cell research and development.
Release SCI Application v3.5, including professional-facing component to help practitioners become more involved in the stem cell research space and contribute to the network.

14
Q4 2020

Expansion and acquisition of SCI stem cell labs and clinics in Europe.

15
Q1 2021

Release SCI earnings and financials report for second year operation and development.
Release public update on SCI stem cell research and development.
Stem Cell Lab Evaluation report for second year.

16
Q2 2021

Release SCI Application v4.0 including:
A new platform for medical students, universities, and hospitals to engage with the SCI Application.
Fully Functional EMR Worldwide Enforcing HIPPA and expanding of synthetic stem cell delivery to Latin America.

Add to bookmarks
ICO KYC Report
2 members invited
Moe Galal
Failed
Ben Barel
Failed
KYC procedure verifies selected/specific team members only. It does not guarantee ICO success nor is a call for investment.
Missing or incorrect data? Let us know.

ICOs that might interest you

4.6

HiveNet

HiveNet is a distributed cloud computing network, which enables computer owners to rent...

39 days 19 hours left
4.4

GRAYLL

GRAYLL is a start & stop system containing algorithms & AI models to automatically gene...

13 days 19 hours left
3.8

Bethereum

Our aim is to become the gold standard for online betting, with bets ranging from sport...

4.6

PointPay

Crypto Bank, Exchange Launched, Wallet Launched , Payment System. PointPay has created ...

646 days 19 hours left

Cookies help us deliver our services. By using our services, you agree to our use of cookies.

Learn more Got it